Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme US$ 27.05 Min. order: 1 piece ★★★★★ 4.5 (19 reviews) Sold : Login>>
Novo Nordisk files for FDA approval for CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues US$ 23.01 Min. order: 1 piece ★★★★★ 5.0 (71 reviews) Sold : Login>>
Novo Nordisk Offers New Contender in Weight Management US$ 26.12 Min. order: 1 piece ★★★★★ 5.0 (160 reviews) Sold : Login>>
Peptide Tools & Guides – Atlas Nutrition US$ 21.65 Min. order: 1 piece ★★★★★ 4.7 (138 reviews) Sold : Login>>
BPC-157 5mg: High Purity Research Peptide for Studies US$ 21.50 Min. order: 1 piece ★★★★★ 4.1 (128 reviews) Sold : Login>>
Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial? US$ 23.18 Min. order: 1 piece ★★★★★ 4.8 (98 reviews) Sold : Login>>